China · Health startup
China · Haalthy
Haalthy is the first & only patient-centric company that uses patient's submitted data to accelerate drug approval in China.
Funding reportedLast round: Series B
What company datasets say Haalthy raised
Funding, as reported
Reported in all33Min the source's currency
Rounds3
Last roundSeries B
Last round size2.8M
Last round dateApr 2019
Investors listed3
The company, in detail
What they build
Known for
healthwellness & fitness serviceswellness & fitness
- Sector
- Health
- Region
- Beijing Shi
- Full record
- Every detail in the company directory
Health in China
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Haalthy in front of investors. Or tell us what we have wrong.